Metabolic Risk Panel
Also known as: Cardiometabolic Risk Panel, Met Risk Panel
Use
Components of the Metabolic Risk Panel identify physiological changes related to cholesterol levels, atherogenic lipoprotein particles, glycemic control, and insulin resistance (e.g., prediabetes/diabetes risk), enabling early identification and intervention before the clinical manifestation of metabolic syndrome or cardiovascular events.
Special Instructions
Components of the Metabolic Risk Panel may be ordered separately using their respective order codes.
Limitations
Not provided.
Methodology
Other
Biomarkers
Result Turnaround Time
5-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.5 mL
Minimum Volume
1.3 mL
Container
Gel‑barrier tube (SST; Gel Barrier)
Patient Preparation
Patient should fast 9‑12 hours prior to specimen collection
Causes for Rejection
Hemolysis; Grossly lipemic; Moderate to grossly icteric; Whole blood other than EDTA (lavender‑top)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | 28 days |